Globus Medical (NYSE:GMED) is up ~8% in after-hours trading Tuesday after raising its 2024 guidance and releasing Q3 ...

Operator Welcome to Globus Medical's third quarter 2024 earnings call. At this time, all lines will be on mute and a Q&A ...

The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major ...

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...

Amalgamated Bank trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.4% in the third quarter, ...

Morgan Stanley raised the firm’s price target on Globus Medical (GMED) to $83 from $74 and keeps an Equal Weight rating on the shares. The company reported “solid” Q3 topline and bottom-line beats, ...

Globus Medical and NuVasive's merger marked its first year on Sept. 1, Globus' CEO Dan Scavilla said in a Nov. 5 earnings call.

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...

Globus Medical, Inc.'s ( NYSE:GMED ) recent soft profit numbers didn't appear to worry shareholders, as the stock ...

Globus Medical will hold a teleconference to discuss its third quarter 2024 results with the investment community at 4:30 p.m ...

AUDUBON, Pa. (AP) — AUDUBON, Pa. (AP) — Globus Medical Inc. (GMED) on Tuesday reported third-quarter net income of $51.8 million. On a per-share basis, the Audubon, Pennsylvania-based company said it ...